Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Cohen

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
The Journal of Clinical Psychiatry|February 12, 2005
Diabetes mellitus during olanzapine and quetiapine treatment in JapanDan Cohen
Environment & Planning A|February 12, 2024
Any Time, Any Place, Any Way, Any Pace: Markets, EdTech, and the spaces of schoolingDan Cohen
Progress in Biophysics and Molecular Biology|December 5, 2023
Family Constellation therapy: A nascent approach for working with non-local consciousness in a therapeutic containerDan Cohen
Nephrology News & Issues|April 13, 2007
Going the distance ... with renal disease. Part 3Dan Cohen
Journal of Clinical Psychopharmacology|July 16, 2008
Scientific standards: critical comments on the pharmacoepidemiological study of second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophreniaDan Cohen
Environment and Planning. C, Politics and Space|April 20, 2026
Philanthropy to the rescue? Detroit's schools and urban policymaking under austerityDan Cohen
The Journal of Clinical Psychiatry|September 15, 2007
Applicability of the oral glucose tolerance test in assessing prevalence and incidence of diabetes mellitus in schizophreniaDan Cohen
Psychiatry and Clinical Neurosciences|September 19, 2007
Effect of risperidone on ghrelin and glucose in schizophreniaDan Cohen
Journal of Opioid Management|January 9, 2018
Abuse-deterrent formulations approval reform: Will clinical correctness or real-world results be used to address the nation's opioid crisis: "Noninterference" as a new approval standardDan Cohen
CNS Drugs|December 13, 2017
Clozapine and Gastrointestinal HypomotilityDan Cohen
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
The Journal of Clinical Psychiatry|February 12, 2005
Diabetes mellitus during olanzapine and quetiapine treatment in JapanDan Cohen
Environment & Planning A|February 12, 2024
Any Time, Any Place, Any Way, Any Pace: Markets, EdTech, and the spaces of schoolingDan Cohen
Progress in Biophysics and Molecular Biology|December 5, 2023
Family Constellation therapy: A nascent approach for working with non-local consciousness in a therapeutic containerDan Cohen
Nephrology News & Issues|April 13, 2007
Going the distance ... with renal disease. Part 3Dan Cohen
Journal of Clinical Psychopharmacology|July 16, 2008
Scientific standards: critical comments on the pharmacoepidemiological study of second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophreniaDan Cohen
Environment and Planning. C, Politics and Space|April 20, 2026
Philanthropy to the rescue? Detroit's schools and urban policymaking under austerityDan Cohen
The Journal of Clinical Psychiatry|September 15, 2007
Applicability of the oral glucose tolerance test in assessing prevalence and incidence of diabetes mellitus in schizophreniaDan Cohen
Psychiatry and Clinical Neurosciences|September 19, 2007
Effect of risperidone on ghrelin and glucose in schizophreniaDan Cohen
Journal of Opioid Management|January 9, 2018
Abuse-deterrent formulations approval reform: Will clinical correctness or real-world results be used to address the nation's opioid crisis: "Noninterference" as a new approval standardDan Cohen
CNS Drugs|December 13, 2017
Clozapine and Gastrointestinal HypomotilityDan Cohen
Pageof 17